Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000987474 | SCV001136771 | pathogenic | Neuronal ceroid lipofuscinosis 7 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002497278 | SCV002809247 | likely pathogenic | Neuronal ceroid lipofuscinosis 7; Macular dystrophy with central cone involvement | 2021-10-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000987474 | SCV003272173 | pathogenic | Neuronal ceroid lipofuscinosis 7 | 2022-04-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro375Leufs*39) in the MFSD8 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MFSD8 are known to be pathogenic (PMID: 19177532, 25227500, 28586915). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MFSD8-related conditions. ClinVar contains an entry for this variant (Variation ID: 802088). For these reasons, this variant has been classified as Pathogenic. |